{"title": "Medicina Tradicional China en el Manejo del Asma Infantil (TraCMAst)", "author": null, "url": "https://ichgcp.net/es/clinical-trials-registry/NCT03645889", "hostname": "ichgcp.net", "description": "El asma bronquial es una enfermedad cr\u00f3nica infantil com\u00fan caracterizada por la inflamaci\u00f3n cr\u00f3nica de las v\u00edas respiratorias. Las reca\u00eddas frecuentes del asma.... Registro de ensayos cl\u00ednicos. ICH GCP.", "sitename": "ichgcp.net", "date": "2017-12-28", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Medicina Tradicional China en el Manejo del Asma Infantil (TraCMAst)\n[KK Women's and Children's Hospital](https://ichgcp.net/es/clinical-trials-registry/research/list?spons=KK%20Women%27s%20and%20Children%27s%20Hospital)\nRol complementario de la medicina tradicional china a base de hierbas en el tratamiento del asma infantil de leve a moderado\nDescripci\u00f3n general del estudio\nEstado\nCondiciones\nIntervenci\u00f3n / Tratamiento\nDescripci\u00f3n detallada\nSe plantea la hip\u00f3tesis de que la Medicina Tradicional China (MTC) a base de hierbas tiene funciones adyuvantes en el tratamiento del asma infantil leve a moderada.\nEl objetivo principal del estudio es investigar la eficacia del uso de la medicina tradicional china a base de hierbas como terapia adyuvante en el tratamiento de los s\u00edntomas y la calidad de vida en pacientes asm\u00e1ticos.\nEl objetivo secundario del estudio es investigar la mejora en la prueba de funci\u00f3n pulmonar (PFT) y la prueba de \u00f3xido n\u00edtrico exhalado fraccionado (FeNO) en pacientes asm\u00e1ticos que toman terapia adyuvante de la MTC a base de hierbas, y monitorear el perfil de seguridad de la MTC a base de hierbas con respecto a la funci\u00f3n renal y renal. funciones hep\u00e1ticas.\nTipo de estudio\nInscripci\u00f3n (Anticipado)\nFase\n- Fase 2\nContactos y Ubicaciones\nEstudio Contacto\n- Nombre: Han Hui Cheong, PhD\n- N\u00famero de tel\u00e9fono: +6563943735\n- Correo electr\u00f3nico:\n[cheong.han.hui@kkh.com.sg](mailto:cheong.han.hui@kkh.com.sg?subject=NCT03645889, 2017/3129, Traditional Chinese Medicine in Management of Childhood Asthma)\nCopia de seguridad de contactos de estudio\n- Nombre: Rupini Piragasam, BSc\n- N\u00famero de tel\u00e9fono: +6563948246\n- Correo electr\u00f3nico:\n[Rupini.Piragasam@kkh.com.sg](mailto:Rupini.Piragasam@kkh.com.sg?subject=NCT03645889, 2017/3129, Traditional Chinese Medicine in Management of Childhood Asthma)\nUbicaciones de estudio\n-\nSingapur\n-\n-\nSingapore, Singapur, 229899\n- Reclutamiento\n- KK Women's and Children's Hospital\n-\nContacto:\n- Han Hui Cheong, PhD\n- N\u00famero de tel\u00e9fono: +6563943735\n- Correo electr\u00f3nico:\n[cheong.han.hui@kkh.com.sg](mailto:cheong.han.hui@kkh.com.sg?subject=NCT03645889, 2017/3129, Traditional Chinese Medicine in Management of Childhood Asthma)\n-\nContacto:\n- Rupini Piragasam, BSc\n- N\u00famero de tel\u00e9fono: +6563948246\n- Correo electr\u00f3nico:\n[Rupini.Piragasam@kkh.com.sg](mailto:Rupini.Piragasam@kkh.com.sg?subject=NCT03645889, 2017/3129, Traditional Chinese Medicine in Management of Childhood Asthma)\n-\nInvestigador principal:\n- Oon Hoe Teoh, MBBS\n-\nSub-Investigador:\n- Han Hui Cheong, PhD\n-\nSub-Investigador:\n- Oh Moh Chay, MBBS\n-\nSub-Investigador:\n- Wei Wei Tan, PharmD\n-\nSub-Investigador:\n- Biju Thomas, MBBS\n-\nSub-Investigador:\n- Anne EN Goh, MBBS\n-\nSub-Investigador:\n- Arun K Pugalenthi, MBBS\n-\nSub-Investigador:\n- Petrina PC Wong, MBBS\n-\nSub-Investigador:\n- Zai Ru Cheng, MBBS\n-\nSub-Investigador:\n- Yi Hua Tan, MBBS\n-\n-\nCriterios de participaci\u00f3n\nCriterio de elegibilidad\nEdades elegibles para estudiar\nAcepta Voluntarios Saludables\nG\u00e9neros elegibles para el estudio\nDescripci\u00f3n\nCriterios de inclusi\u00f3n:\n- Tener asma que est\u00e1 parcialmente controlada seg\u00fan la gu\u00eda de clasificaci\u00f3n de control del asma de la Iniciativa Global para el Asma (GINA) y tiene una puntuaci\u00f3n en la Prueba de control del asma (ACT) \u226517 en el momento del reclutamiento.\n- Actualmente usa fluticasona como la \u00fanica terapia regular con corticosteroides inhalados para el control del asma con dosis de fluticasona \u2264 250 mcg/d\u00eda durante al menos los \u00faltimos 3 meses.\n- Capaz de realizar prueba de funci\u00f3n pulmonar\n- Cumplir con los criterios de la medicina tradicional china del tipo de asma \"deficiencia de qi de pulm\u00f3n-bazo\"\nCriterio de exclusi\u00f3n:\n- Resultados de laboratorio para funciones renales y hep\u00e1ticas fuera del rango normal.\n- Uso concomitante de teofilina o montelukast.\n- Concomitantemente o en los \u00faltimos 3 meses tomando TCM\n- Embarazada o lactancia\n- Reacciones al\u00e9rgicas conocidas a alimentos como el man\u00ed, los mariscos, el huevo y la leche\nPlan de estudios\n\u00bfC\u00f3mo est\u00e1 dise\u00f1ado el estudio?\nDetalles de dise\u00f1o\n- Prop\u00f3sito principal: Tratamiento\n- Asignaci\u00f3n: Aleatorizado\n- Modelo Intervencionista: Asignaci\u00f3n paralela\n- Enmascaramiento: Cuadruplicar\nArmas e Intervenciones\n|\n|\nGrupo de participantes/brazo\n|\n|\nIntervenci\u00f3n / Tratamiento\n|\n|\nExperimental: T\u00f3nico pulmonar pedi\u00e1trico (PLTG)\nMedicina Tradicional China (MTC) en forma de dosificaci\u00f3n de gr\u00e1nulos para disolver para el consumo.\n|\n|\nUna combinaci\u00f3n de 13 gr\u00e1nulos de hierbas.\n|\n|\nComparador de placebos: PLTG Placebo\nGr\u00e1nulos de almid\u00f3n con un 10 % de TCM para imitar el color, el sabor y el olor de la TCM activa.\n|\n|\n90% relleno de almid\u00f3n y 10% PLTG\n\u00bfQu\u00e9 mide el estudio?\nMedidas de resultado primarias\n|\n|\nMedida de resultado\n|\n|\nMedida Descripci\u00f3n\n|\n|\nPeriodo de tiempo\n|\n|\nCambio en la calidad de vida del asma pedi\u00e1trica desde el inicio a los 3 meses\nPeriodo de tiempo: 3 meses\n|\n|\nEl cuestionario de calidad de vida del asma pedi\u00e1trica se utilizar\u00e1 para evaluar la mejora de los s\u00edntomas asm\u00e1ticos y la calidad de vida en pacientes que reciben un r\u00e9gimen de tratamiento convencional para el asma y medicina tradicional china.\n|\n|\n3 meses\nMedidas de resultado secundarias\n|\n|\nMedida de resultado\n|\n|\nMedida Descripci\u00f3n\n|\n|\nPeriodo de tiempo\n|\n|\nCambio en la funci\u00f3n pulmonar pulmonar desde el inicio a los 3 meses\nPeriodo de tiempo: 3 meses\n|\n|\nLa mejora de la funci\u00f3n pulmonar pulmonar se evaluar\u00e1 mediante una prueba de espirometr\u00eda.\n|\n|\n3 meses\n|\n|\nIncidencia de eventos adversos relacionados con el h\u00edgado emergentes del tratamiento\nPeriodo de tiempo: 3 meses\n|\n|\nPruebas de bioqu\u00edmica cl\u00ednica para evaluar las funciones hep\u00e1ticas\n|\n|\n3 meses\n|\n|\nIncidencia de eventos adversos renales emergentes del tratamiento\nPeriodo de tiempo: 3 meses\n|\n|\nPruebas de bioqu\u00edmica cl\u00ednica para evaluar las funciones renales\n|\n|\n3 meses\n|\n|\nCambio en la inflamaci\u00f3n de las v\u00edas respiratorias desde el inicio a los 3 meses\nPeriodo de tiempo: 3 meses\n|\n|\nReducci\u00f3n del \u00f3xido n\u00edtrico exhalado faccionario como indicador de mejora en la inflamaci\u00f3n de las v\u00edas respiratorias.\n|\n|\n3 meses\nColaboradores e Investigadores\nPatrocinador\nColaboradores\nInvestigadores\n- Investigador principal: Oon Hoe Teoh, MBBS, KK Women's and Children's Hospital\nFechas de registro del estudio\nFechas importantes del estudio\nInicio del estudio (Actual)\nFinalizaci\u00f3n primaria (Anticipado)\nFinalizaci\u00f3n del estudio (Anticipado)\nFechas de registro del estudio\nEnviado por primera vez\nPrimero enviado que cumpli\u00f3 con los criterios de control de calidad\nPublicado por primera vez (Actual)\nActualizaciones de registros de estudio\n\u00daltima actualizaci\u00f3n publicada (Actual)\n\u00daltima actualizaci\u00f3n enviada que cumpli\u00f3 con los criterios de control de calidad\n\u00daltima verificaci\u00f3n\nM\u00e1s informaci\u00f3n\nT\u00e9rminos relacionados con este estudio\nPalabras clave\nT\u00e9rminos MeSH relevantes adicionales\nOtros n\u00fameros de identificaci\u00f3n del estudio\n- 2017/3129\nPlan de datos de participantes individuales (IPD)\n\u00bfPlanea compartir datos de participantes individuales (IPD)?\nInformaci\u00f3n sobre medicamentos y dispositivos, documentos del estudio\nEstudia un producto farmac\u00e9utico regulado por la FDA de EE. UU.\nEstudia un producto de dispositivo regulado por la FDA de EE. UU.\nEsta informaci\u00f3n se obtuvo directamente del sitio web\n[clinicaltrials.gov](https://clinicaltrials.gov) sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comun\u00edquese con [register@clinicaltrials.gov](mailto:register@clinicaltrials.gov). Tan pronto como se implemente un cambio en [clinicaltrials.gov](https://clinicaltrials.gov), tambi\u00e9n se actualizar\u00e1 autom\u00e1ticamente en nuestro sitio web. .\nEnsayos cl\u00ednicos sobre Asma en ni\u00f1os\n-\nNCT06003569A\u00fan no reclutando\n-\nNCT05997784A\u00fan no reclutando\n-\nNCT05992519Reclutamiento\n-\nNCT05992389ReclutamientoAsma en ni\u00f1os | Contaminaci\u00f3n; Exposici\u00f3n\n-\nNCT05985720A\u00fan no reclutandoDisfunci\u00f3n ventricular | Asma en ni\u00f1os\n-\nNCT05991115A\u00fan no reclutando\n-\nNCT05974917A\u00fan no reclutando\n[Los juegos serios como intervenciones emergentes de salud electr\u00f3nica para j\u00f3venes con trastornos neurol\u00f3gicos o respiratorios (SMILER)](https://ichgcp.net/es/clinical-trials-registry/NCT05974917)Asma en ni\u00f1os | Ni\u00f1os, Solo | Juego serio\n-\nNCT05945355A\u00fan no reclutandoObesidad | Obesidad Pedi\u00e1trica | Asma en ni\u00f1os | Asma pedi\u00e1trica\n-\nNCT05934370Reclutamiento\n-\nNCT05902702A\u00fan no reclutandoAsma en ni\u00f1os | Bronquiolitis | Enfermedad respiratoria | Infecci\u00f3n Respiratoria Aguda | Infecci\u00f3n viral", "language": null, "image": null, "pagetype": "website", "links": ["https://ichgcp.net/es", "#", "https://ichgcp.net/de", "https://ichgcp.net/", "https://ichgcp.net/es", "https://ichgcp.net/fr", "https://ichgcp.net/it", "https://ichgcp.net/pt", "https://ichgcp.net/ru", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/ich-e-group-of-guidelines", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/events", "https://ichgcp.net/es/clinical-trials-registry/publications", "https://ichgcp.net/es/clinical-trials-registry/researchers", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/clinical-trials-registry/NCT03645889", "https://telegram.me/share/url?url=https://ichgcp.net/es/clinical-trials-registry/NCT03645889&text=", "https://twitter.com/intent/tweet?url=https://ichgcp.net/es/clinical-trials-registry/NCT03645889", "https://ichgcp.net/es", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=KK%20Women%27s%20and%20Children%27s%20Hospital", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Asthma%20in%20Children", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=PLTG", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Placebo", "mailto:cheong.han.hui@kkh.com.sg?subject=NCT03645889, 2017/3129, Traditional Chinese Medicine in Management of Childhood Asthma", "mailto:Rupini.Piragasam@kkh.com.sg?subject=NCT03645889, 2017/3129, Traditional Chinese Medicine in Management of Childhood Asthma", "mailto:cheong.han.hui@kkh.com.sg?subject=NCT03645889, 2017/3129, Traditional Chinese Medicine in Management of Childhood Asthma", "mailto:Rupini.Piragasam@kkh.com.sg?subject=NCT03645889, 2017/3129, Traditional Chinese Medicine in Management of Childhood Asthma", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=PLTG", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Placebo", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=KK%20Women%27s%20and%20Children%27s%20Hospital", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Singapore%20Thong%20Chai%20Medical%20Institution", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=Traditional%20Chinese%20Medicine", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Respiratory%20Tract%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Immune%20System%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Lung%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Hypersensitivity%2C%20Immediate", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Bronchial%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Lung%20Diseases%2C%20Obstructive", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Respiratory%20Hypersensitivity", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Hypersensitivity", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Asthma", "https://clinicaltrials.gov", "mailto:register@clinicaltrials.gov", "https://clinicaltrials.gov", "https://ichgcp.net/es/clinical-trials-registry/NCT06003569", "https://ichgcp.net/es/clinical-trials-registry/NCT05997784", "https://ichgcp.net/es/clinical-trials-registry/NCT05992519", "https://ichgcp.net/es/clinical-trials-registry/NCT05992389", "https://ichgcp.net/es/clinical-trials-registry/NCT05985720", "https://ichgcp.net/es/clinical-trials-registry/NCT05991115", "https://ichgcp.net/es/clinical-trials-registry/NCT05974917", "https://ichgcp.net/es/clinical-trials-registry/NCT05945355", "https://ichgcp.net/es/clinical-trials-registry/NCT05934370", "https://ichgcp.net/es/clinical-trials-registry/NCT05902702", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assistance%2BPublique%2B-%2BH%25C3%25B4pitaux%2Bde%2BParis", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=AstraZeneca", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=SeeCure%2BLLC", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=GlaxoSmithKline", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidade%2Bde%2BLisboa%252C%2BPortugal", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Mayo%2BClinic", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assiut%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidad%2Bdel%2BZulia", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Center%2Bfor%2BIndustrial%2BTechnological%2BDevelopment%2Bof%2BSpain", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=European%2BSociety%2Bof%2BHuman%2BReproduction%2Band%2BEmbryology", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Orphanetics%2BPharma%2BEntwicklungs%2BGmbH", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=M.D.%2BAnderson%2BCancer%2BCenter", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Medtronic%2BSurgical%2BTechnologies", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pfizer", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Cairo%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Jos%25C3%25A9phine%2BSOLTANI%252C%2BCardiology%2Bdepartment%252C%2BVersailles%2BHospital", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pediatric%2BOrthopaedic%2BSociety%2Bof%2BNorth%2BAmerica", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=National%2BCancer%2BInstitute%2B%2528NCI%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Novartis%2BPharmaceuticals", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Kaneka%2BAmericas%2BHolding%2BInc.", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Malignant%2BNeoplasm%2Bof%2BRespiratory%2Band%2BIntrathoracic%2BOrgan%2BCarcinoma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pain", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Esophageal%2BResection%2BCandidates", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ultrasound%2BEvaluation", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma%252C%2BAdrenal%2BCortical", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronary%2BArtery%2BDisease", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=HIV%2BInfections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Postneoadjuvant%2BTherapy%2BStage%2BI%2BGastric%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Obesity", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Depression", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%2BI%2BGallbladder%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Asthma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Prostate%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Breast%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ankle%2BArthroplasty", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stroke", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Cushing%2527s%2BSyndrome%2BI", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colon%2BMalignant%2BTumor", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Post-traumatic%2BAnosmia", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Hypertension", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Oral%2BGlucose%2BGel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Brimonidine%2Btartrate%2Bophthalmic%2Bsolution%2B0.025%2525%2B%2528n%2B%253D%2B56%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Carboplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Docetaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Gemcitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Alpelisib%2B150%2BMG%2BOral%2BTablet%2B%255BPiqray%255D", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Bevacizumab", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Capecitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Prednisone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cyclophosphamide", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=20mg%2BAzilsartan%2BTablets", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Pilocarpine%2B1.25%2525%2BEye%2Bdrop", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Valacyclovir%2Barrow", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Teicoplanin%2BSandoz%2B200%2Bmg%2Bpowder%2Band%2Bsolvent%2Bfor%2Bsolution%2Bfor%2Binjection%2Bor%2Binfusion%2Bor%2Boral%2Bsolution.", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=MK-8521%2B100%25CE%25BCg", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Paclitaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Injectafer", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Transplant%2B2%2BMelphalan", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Dexamethasone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cisplatin", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/cro-list/country/albania", "https://ichgcp.net/es/cro-list/country/algeria", "https://ichgcp.net/es/cro-list/country/armenia", "https://ichgcp.net/es/cro-list/country/bahamas", "https://ichgcp.net/es/cro-list/country/cambodia", "https://ichgcp.net/es/cro-list/country/congo", "https://ichgcp.net/es/cro-list/country/gabon", "https://ichgcp.net/es/cro-list/country/hungary", "https://ichgcp.net/es/cro-list/country/iran", "https://ichgcp.net/es/cro-list/country/mauritania", "https://ichgcp.net/es/cro-list/country/saint_lucia", "https://ichgcp.net/es/cro-list/country/singapore", "https://ichgcp.net/es/cro-list/country/united_kingdom", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/cro-list/country/oman/company/sgs", "https://ichgcp.net/es/cro-list/country/oman", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/ord_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_cat", "https://ichgcp.net/es", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/guideline-for-the-notification-of-serious-breaches-of-regulation-eu-no-536-2014", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/about-us-our-mission", "https://ichgcp.net/es/sitemap", "https://ichgcp.net/es/contact-us", "https://ichgcp.net/es/feed", "/privacy", "/disclaimer", "https://ichgcp.net/da/clinical-trials-registry/NCT03645889", "https://ichgcp.net/de/clinical-trials-registry/NCT03645889", "https://ichgcp.net/clinical-trials-registry/NCT03645889", "https://ichgcp.net/es/clinical-trials-registry/NCT03645889", "https://ichgcp.net/fr/clinical-trials-registry/NCT03645889", "https://ichgcp.net/it/clinical-trials-registry/NCT03645889", "https://ichgcp.net/hu/clinical-trials-registry/NCT03645889", "https://ichgcp.net/nl/clinical-trials-registry/NCT03645889", "https://ichgcp.net/no/clinical-trials-registry/NCT03645889", "https://ichgcp.net/pl/clinical-trials-registry/NCT03645889", "https://ichgcp.net/pt/clinical-trials-registry/NCT03645889", "https://ichgcp.net/fi/clinical-trials-registry/NCT03645889", "https://ichgcp.net/sv/clinical-trials-registry/NCT03645889", "https://ichgcp.net/cs/clinical-trials-registry/NCT03645889", "https://ichgcp.net/ru/clinical-trials-registry/NCT03645889", "https://ichgcp.net/ja/clinical-trials-registry/NCT03645889", "https://ichgcp.net/zh/clinical-trials-registry/NCT03645889", "https://ichgcp.net/ko/clinical-trials-registry/NCT03645889", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf"]}